期刊文献+

Caco-2细胞模型——药物吸收研究的有效“工具” 被引量:38

Caco-2 cell model——an effective tool for the research of drug absorption
下载PDF
导出
摘要 吸收过程是决定口服药物生物利用度的重要因素 ,然而很多药物的吸收机制还不明确。Caco 2细胞模型是目前最好的体外吸收模型 ,在药物的吸收过程及吸收机制的研究方面有广泛的应用 ,尤其在中药吸收研究方面 ,Caco 2细胞模型的应用成为目前的热点。另外 ,Caco 2细胞模型在药物代谢方面也有应用。因此 ,Caco 2细胞模型将成为药物吸收研究的重要手段 ,有助于加快新药筛选和开发的速度。 The absorption process is an important factor in determining the bioavailability of orally administered drugs. however, the absorption mechanism of many drugs is not clear. Caco-2 cell model is the best in vitro absorption model nowadays. It is widely used in the research on drug absorption process and absorption mechanism, especially in the aspect of traditional Chinese medicine absorption, the use of Caco-2 cell model has become the hot spot recently. Mo- reover, Caco-2 cell model is also applied in the research on drug metabolism. Therefore, Caco-2 cell model will become an important method in the research of drug absorption, and will be helpful to accelerate the process of new drug screening and development.
出处 《中国药理学通报》 CAS CSCD 北大核心 2004年第6期609-614,共6页 Chinese Pharmacological Bulletin
关键词 CACO-2细胞模型 药物吸收 吸收机制 Caco-2 cell model drug absorption absorption mechanism
  • 相关文献

参考文献25

  • 1Gan LS,Thankker DR.Applications of the Caco-2 model in the design and development of biochemical and physical barriers posed by the intestinal epithelium.Adv Drug Delivery Rev,1997;23(1~3):77~98
  • 2Workshop on oral drug delivery:Interface between discovery and development-report and recommendations,national institute of general medical sciences.Bethesda MD,1993
  • 3Stenberg P,Bergstrom CA,Luthman K,Artursson P.Theoretical predictions of drug absorption in drug discovery and development.Clin Pharmacokinet,2002;41(11):877~99
  • 4Annette B,Sibylle H,Kayoshi S et al.Cell cultures as tools in biopharmacy.Eur J Pharm Sci,2000;11(Suppl 2):51~60
  • 5Yee S.In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth.Pharm Res,1997;14(6):763~6
  • 6Carriere V,Lesuffleur T,Barbat A et al.Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.FEBS Lett,1994;355(3):247~50
  • 7Artursson P,Karlsson J.Correlation between oral drug absorption in human and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.Biochem Biophys Res Commun,1991;175(3):880~5
  • 8Rouquayrol M,Gaucher B,Roche D et al.Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir,indinavir,and nelfinavir across Caco-2 cell monolayers.Pharm Res,2002;19(11):1704~12
  • 9Udata C,Patel J,Pal D et al.Enhanced transport of a novel anti-HIV agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.Int J Pharm,2003;250(1):157~68
  • 10Yamashita S,Furubayashi T,Kataoka M et al.Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.Eur J Pharm Sci,2000;10(3):195~204

二级参考文献23

  • 1Hoffermeyers S, Burk O, von Richter 0 et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 2000,97:3473-8.
  • 2Parreboom A, Van Asperen J, Mayer U et al, Limited oral bioavailability and active eothelial excertion of paclitaxel(Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA, 1997,94:2031-5.
  • 3Meerm Terwogt JM, Beijnen JH, ten Bokkel Huinink WW et al. Co-adiministratlon of cyclosporin enables oral therapy with paclitaxel. Lancet, 1998;352:285.
  • 4Kim Rb, Fromm MF, Wandel C etal. The drug transporter P-glycoprotein limits oral absoption and brain entry of HIV-1 protease inhibitors. J Clin Invest, 1998 ; 101 : 289-94.
  • 5Schellen JHM, Malingre MM, Kruijtzer CMF et al. Modulaton of oral bioavailability of antieaneer drugs: From mouse to man. Eur J Pharma Sci, 2000;12:103-10.
  • 6Bent LZ, Kroetz DL, Sheiner LB. Pharmacokkinetics: The dynamics of drug absorption, distribution, and elimination. In:Hardman JH, Limbird LE, Molinoff PB, et al., editors.Goodman & Gilman's the pharmacological basis of therapetics.New York, McGraw-Hill. 1996,3-28.
  • 7Wacher VJ, Silverman JA, Zhang Y et al. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidominetics. J Pharm Sci, 1998;87:1322-30.
  • 8Higgins CF, ABC transporters: From microorganisms to man,Annu Rev Cell Biol, 1992,8:67 - 113.
  • 9Schinkel AH, Smit JJ, van Tellingen 0 etal. Disrupion of the mouse mdrla P-glycopreotein gene leads to a deficiency in the blood brain barrier and to increased sensitivity to drugs. Cell,1994,77:491-502.
  • 10Schumacher U, mollgard K. The multidrug-resistance P-glycoprotein (P-gp, MDR1) I art early marker of blood-brain barrier development in the microvessels of the developing of human brain, Histochern Cell Biol, 1997;108:179--82.

共引文献24

同被引文献500

引证文献38

二级引证文献240

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部